Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00121472 · ClinicalTrials.gov registry record · NA
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT00121472 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 194 participants.
The verdict
NCT00121472, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of the Thoratec HeartMate II Left Ventricular Assist System (LVAS) as a bridge to cardiac transplantation in end-stage heart failure patients who are listed for cardiac transplant but are at imminent risk of dying. The HeartMate II LVAS was approved by the US FDA on April 21, 2008, as a bridge to cardiac transplantation (reference PMA P060040). It was approved for commercial distribution in Canada on May 20, 2009 (reference Medical Device Licence #79765). Patients enrolled into the clinical trial will continue to be followed until all have reached a clinical outcome.
Interventions
- DEVICE Thoratec HeartMate II Left Ventricular Assist System (LVAS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00121472
The ClinicalTrials.gov registry entry for NCT00121472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thoratec HeartMate II Left Ventricular Assist System (LVAS) is the first listed.
NCT00121472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00121472 about?
NCT00121472 is a clinical study titled "Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation". The purpose of this study is to determine the safety and effectiveness of the Thoratec HeartMate II Left Ventricular Assist System (LVAS) as a bridge to cardiac transplantation in end-stage heart failure patients who are listed for cardiac transplant but are at imminent risk of dying. The HeartMate...
What is the current status of trial NCT00121472?
This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2005-03. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00121472?
The interventions under investigation include: Thoratec HeartMate II Left Ventricular Assist System (LVAS) (DEVICE).
Who is sponsoring clinical trial NCT00121472?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.